Example Output: Healthcare Life Science Risk Governance Review
Inputs used
- Project context: a clinic operations assistant that summarizes appointment preparation tasks
- Target audience: clinical operations, life science teams, patient experience, health tech PMs
- Success metric: activation, quality, and risk reduction
- Available tools and data: SOP repository, EHR export with safeguards, quality dashboard, review queue
- Desired depth: Production-ready
- Output tone: Clear operator memo
Generated Result
risk register, severity ranking, controls, and verification checklist
System boundary
Use workflow SOPs as evidence, apply the constraint "no diagnosis or treatment advice", and explicitly note how the plan reduces clinical overreach. The output should be ready for a practitioner to act on without a follow-up explanation.
Data sensitivity
Treat PHI exposure as a launch blocker until there is a control that can be verified. The minimum control is: use de-identified data, plus reviewer sign-off for ambiguous outputs.
Risk register
Treat protocol misinterpretation as a launch blocker until there is a control that can be verified. The minimum control is: human review for patient impact, plus reviewer sign-off for ambiguous outputs.
Controls
Treat equity blind spots as a launch blocker until there is a control that can be verified. The minimum control is: no diagnosis or treatment advice, plus reviewer sign-off for ambiguous outputs.
Residual risk
Treat clinical overreach as a launch blocker until there is a control that can be verified. The minimum control is: use de-identified data, plus reviewer sign-off for ambiguous outputs.
Verification checklist
Use de-identified notes as evidence, apply the constraint "human review for patient impact", and explicitly note how the plan reduces PHI exposure. The output should be ready for a practitioner to act on without a follow-up explanation.
Recommended Decision
Proceed with a narrow pilot focused on workflow SOPs and de-identified notes. Treat clinical overreach as the primary launch blocker. The first milestone should prove that the workflow produces a usable safe workflow brief, escalation rules, and audit checklist with clear evidence, named owners, and a review path for ambiguous cases.
Expected quality checks
- The result is specific to AI-assisted patient ops, protocol comprehension, life science research support, and quality review.
- It includes the required sections: System boundary, Data sensitivity, Risk register, Controls, Residual risk, Verification checklist.
- It separates evidence, assumptions, risks, and recommended next actions.
- It includes practical verification steps, not only generic advice.
- It names the most important failure mode for this domain: clinical overreach.
Reuse note
Before copying the output into production work, replace all default variables with your real data and run a human review for high-impact decisions.